ArticleCell reports2023

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy.

Sudipta Biswas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.